You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,071,970


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,071,970
Title: Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
Abstract:Method and compositions for treating a patient having a neurological disease or disorder, such as stroke, head trauma, spinal cord injury, epilepsy, anxiety, or neurodegenerative diseases such as Alzheimer's Disease, Huntington's Disease, Parkinson's Disease, or amyotrophic lateral sclerosis (ALS).
Inventor(s): Mueller; Alan L. (Salt Lake City, UT), Balandrin; Manuel F. (Sandy, UT), VanWagenen; Bradford C. (Salt Lake City, UT), DelMar; Eric G. (Salt Lake City, UT), Moe; Scott T. (Salt Lake City, UT), Artman; Linda D. (Salt Lake City, UT), Barmore; Robert M. (Salt Lake City, UT)
Assignee: NPS Pharmaceuticals, Inc. (Salt Lake City, UT)
Application Number:08/485,038
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,071,970
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 6,071,970

Introduction

United States Patent 6,071,970, titled "Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases," is a patent that has significant implications in the field of neurology and pharmaceuticals. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

Publication Details

  • Publication Number: US6071970A
  • Filing Date: The patent was filed on March 22, 1996, as indicated by the application number US08/485,038[4].
  • Grant Date: The patent was granted on June 6, 2000.
  • Legal Status: The patent has expired, marking the end of its lifetime[4].

Scope of the Invention

The patent describes compounds that are active at a novel site on receptor-operated calcium channels. These compounds are designed for the treatment of various neurological diseases and disorders, including stroke, head trauma, spinal cord injury, and epilepsy.

Key Aspects

  • Compounds: The invention involves a class of compounds that interact with receptor-operated calcium channels in a novel manner. These compounds are intended to modulate the activity of these channels, which is crucial in the context of neurological disorders[4].
  • Therapeutic Applications: The patent highlights the therapeutic potential of these compounds in treating a range of neurological conditions. This includes their use in reducing the severity of neurological damage and improving patient outcomes[4].

Claims of the Patent

The claims of a patent are critical as they define the scope of the invention and what is protected by the patent.

Independent and Dependent Claims

  • Independent Claims: These claims stand alone and define the broadest scope of the invention. For US6071970A, the independent claims would typically describe the novel compounds and their use in treating neurological disorders[4].
  • Dependent Claims: These claims are narrower and depend on the independent claims. They often provide additional details or specific embodiments of the invention, such as particular chemical structures or methods of administration.

Claim Structure

The claim structure in a patent like US6071970A would typically follow a hierarchical format, with broader claims at the top and more specific claims below. This structure helps in defining the invention's scope and ensuring that the patent covers all relevant aspects of the invention.

Patent Landscape

Understanding the patent landscape is crucial for assessing the impact and relevance of a patent.

Prior Art

Prior art refers to the existing body of knowledge in the field at the time of the patent application. For US6071970A, prior art would include other patents, publications, and known practices related to receptor-operated calcium channels and neurological treatments. The patent must demonstrate a novel and non-obvious improvement over this prior art to be granted[4].

Global Dossier and International Patent Offices

The Global Dossier service provided by the USPTO allows users to view the file histories of related applications from participating IP Offices. This can help in understanding how similar inventions are treated globally and whether there are corresponding patents in other jurisdictions[1].

Searchable Databases

Utilizing databases such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO) can provide a comprehensive view of the global patent landscape related to neurological treatments and calcium channel modulators[1].

Determining Inventorship

Inventorship is a critical aspect of patent law, and it is defined by the conception and reduction to practice of the invention.

Conception and Reduction to Practice

  • Conception: This involves the formation in the mind of the inventor of a definite and permanent idea of the complete and operative invention. For US6071970A, the inventors would have conceived the idea of using specific compounds to modulate receptor-operated calcium channels[2].
  • Reduction to Practice: This step involves either building and testing the invention or describing it in sufficient detail so that one with ordinary skill in the field could make and use it without undue experimentation[2].

Economic and Research Implications

The Patent Claims Research Dataset provided by the USPTO can offer insights into the economic and research implications of patents like US6071970A.

Patent Scope Measurements

The dataset includes detailed information on claims from U.S. patents and applications, which can help in analyzing the scope and impact of the patent. This includes measures of patent scope and the dependency relationship between claims[3].

Research Trends

Analyzing the trends in patent scope measurements and the data from the Patent Claims Research Dataset can provide insights into how patents like US6071970A contribute to the broader landscape of neurological research and treatment development[3].

Key Takeaways

  • Patent Scope: US6071970A covers compounds active at a novel site on receptor-operated calcium channels, with significant therapeutic potential for neurological disorders.
  • Claims Structure: The patent includes independent and dependent claims that define the scope of the invention and its specific embodiments.
  • Patent Landscape: Understanding the global patent landscape through tools like Global Dossier and international patent databases is crucial for assessing the patent's impact.
  • Inventorship: Correct determination of inventorship is vital, focusing on the conception and reduction to practice of the invention.
  • Economic and Research Implications: The patent contributes to the advancement of neurological treatments and can be analyzed through datasets like the Patent Claims Research Dataset.

FAQs

  1. What is the main subject of US Patent 6,071,970?

    • The main subject is compounds active at a novel site on receptor-operated calcium channels, useful for treating neurological disorders and diseases.
  2. How do you determine the inventorship for a patent like US6071970A?

    • Inventorship is determined by identifying who conceived the idea of the invention and reduced it to practice, focusing on the conception step as defined by patent law[2].
  3. What tools can be used to search for similar patents globally?

    • Tools like the Global Dossier, European Patent Office's esp@cenet, Japan Patent Office's database, and WIPO's PATENTSCOPE can be used to search for similar patents globally[1].
  4. Why is the Patent Claims Research Dataset important for analyzing patents?

    • The dataset provides detailed information on claims, claim-level statistics, and document-level statistics, helping in analyzing the scope and impact of patents[3].
  5. What happens when a patent like US6071970A expires?

    • When a patent expires, the invention enters the public domain, and anyone can use, make, and sell the invention without needing permission from the original patent holder[4].

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,071,970

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.